Follow
Michael J. Scalese
Michael J. Scalese
Auburn University Harrison School of Pharmacy
Verified email at auburn.edu
Title
Cited by
Cited by
Year
Management of oral anticoagulation therapy after gastrointestinal bleeding: whether to, when to, and how to restart an anticoagulation therapy
K Kido, MJ Scalese
Annals of Pharmacotherapy 51 (11), 1000-1007, 2017
332017
Nebulized Heparin With N-Acetylcysteine and Albuterol Reduces Duration of Mechanical Ventilation in Patients With Inhalation Injury
KA McGinn, K Weigartz, A Lintner, MJ Scalese, SA Kahn
Journal of pharmacy practice 32 (2), 163-166, 2019
322019
Role of digoxin in atrial fibrillation
MJ Scalese, DJ Salvatore
Journal of Pharmacy Practice 30 (4), 434-440, 2017
312017
Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors
MJ Scalese, TS Reinaker
American Journal of Health-System Pharmacy 73 (12), 873-879, 2016
232016
Assessment of apixaban prescribing patterns for nonvalvular atrial fibrillation in hospitalized patients
CM Gibson, CB Smith, S Davis, MJ Scalese
Annals of Pharmacotherapy 52 (1), 54-59, 2018
222018
Propofol-associated QTc prolongation
MJ Scalese, HR Herring, RC Rathbun, GH Skrepnek, TL Ripley
Therapeutic Advances in Drug Safety 7 (3), 68-78, 2016
132016
Antithrombotic therapy post endovascular stenting for superior vena cava syndrome
MJ Scalese, SL Hayes, S Lott
Hospital pharmacy 52 (10), 666, 2017
52017
A case-based approach for teaching medication safety to pharmacy students
MJ Scalese, J Kristeller, E Hoot, F Kong
Currents in Pharmacy Teaching and Learning 7 (4), 458-464, 2015
52015
Metoclopramide-induced asystolic cardiac arrest
MH Al-Shaer, MS Mustafa, MJ Scalese
Annals of Pharmacotherapy 49 (5), 610-611, 2015
52015
Current practices for identifying and managing challenging pharmacy residents: A needs assessment
T Hellwig, CR Williams, C Jen, JN Raub, M Scalese, WJ Smith, ...
American Journal of Health-System Pharmacy 77 (1), 52-55, 2020
32020
Dipeptidyl Peptidase-4 Inhibitor–Associated Risk of Bleeding: An Evaluation of Reported Adverse Events
MM Rahman, MJ Scalese, RA Hansen
Annals of Pharmacotherapy 51 (7), 563-569, 2017
32017
Profound hyperkalemia associated with thromboprophylactic enoxaparin
MJ Scalese
Therapeutic Advances in Drug Safety 7 (3), 120-121, 2016
22016
Evaluating the effectiveness of Tisdale risk scoring tool in predicting cardiac events.
D Jensen, F Vahora, M Ng, C Cai, M Khazan, M Scalese, JF Cox
2022 ACCP Virtual Poster Symposium (May 24 and 25), 2022
2022
An Exploratory Study Using QTc Scoring Tool in CCU Patients.
V Araujo, M Currie, K Phelps, C Jackson-Jones, M Khazan, C Cai, ...
ACCP Virtual Poster Symposium, May 26 and 27, 2020, 2020
2020
Feasibility of apixaban dose adjustment recommendations in atrial fibrillation
C Gibson, CB Smith, M Scalese
PHARMACOTHERAPY 36 (12), E215-E215, 2016
2016
An evaluation of factors associated with QTc-Interval prolongation in patients receiving propofol.
M Scalese, H Herring, RC Rathbun, G Skrepnek, T Ripley
PHARMACOTHERAPY 34 (10), E186-E186, 2014
2014
Research & Reviews: Journal of Hospital and Clinical Pharmacy
SL Hayes, S Lott, MJ Scalese
Beta blockers in heart failure with preserved ejection frac-tion and reactive airway disease
MJ Scalese
Research & Reviews: Journal of Hospital and Clinical Pharmacy
MMW Sadek
The system can't perform the operation now. Try again later.
Articles 1–19